Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
463 JPY | +3.12% | +2.43% | -19.90% |
May. 09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
Mar. 13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
Business Summary
Number of employees: 45
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Regenerative Medicine
100.0
%
| 23 | 100.0 % | 2,350 | 100.0 % | +10,128.06% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 23 | 100.0 % | 2,350 | 100.0 % | +10,128.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 19-02-28 | |
Kensuke Tomita
CHM | Chairman | 75 | 13-06-30 |
Tomoyuki Hoshino
ADM | Chief Administrative Officer | - | - |
Chief Tech/Sci/R&D Officer | 53 | 07-03-31 | |
Koichi Yokota
CTO | Chief Tech/Sci/R&D Officer | 66 | 13-08-31 |
Tsutomu Kanesaki
PRN | Corporate Officer/Principal | 51 | 10-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 19-02-28 | |
Kensuke Tomita
CHM | Chairman | 75 | 13-06-30 |
Koichi Yokota
CTO | Chief Tech/Sci/R&D Officer | 66 | 13-08-31 |
Noriko Sawai
BRD | Director/Board Member | 52 | 19-09-30 |
Tsutomu Kanesaki
PRN | Corporate Officer/Principal | 51 | 10-04-30 |
Chief Tech/Sci/R&D Officer | 53 | 07-03-31 | |
Hirotada Nagai
BRD | Director/Board Member | 47 | 20-10-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 61,508,200 | 25,590,279 ( 41.60 %) | 121 ( 0.000197 %) | 41.60 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.90% | 176M | |
-2.29% | 89.38B | |
-3.68% | 37.92B | |
-13.55% | 32.04B | |
+63.05% | 26.03B | |
-22.69% | 14.14B | |
-8.07% | 12.88B | |
-9.33% | 11.77B | |
-46.28% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- 4599 Stock
- Company StemRIM